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A commentary on
Reversal of cocaine-evoked synaptic 
potentiation resets drug-induced adaptive 
behaviour
by Pascoli, V., Turiault, M., and Lüscher, C. 
(2011). Nature 481, 71–75.
In western industrialized nations approxi-
mately 25% of all deaths are caused directly 
or indirectly by the consumption of psy-
chotropic substances. Substance-related 
addictions therefore constitute the most 
frequently occurring psychiatric disease 
category (McGinnis and Foege, 1993). The 
etiology of addiction due to psychoactive 
substances is highly multi-factorial. These 
factors being social and environmental 
influences, a person’s individual biography, 
personality traits, and genetic predisposi-
tion as far as the susceptibility to substance-
dependence is concerned. However, from 
a neuropathophysiological point of view, 
addiction is a chronically recurring disease 
of the brain resulting from a dysregulation 
of neural circuits. Especially a dysregulation 
of the mesocorticolimbic pathway, including 
the nucleus accumbens (NAcc), is considered 
to play a major role in this context (Adinoff, 
2004). Recent understanding of the neural 
pathways affected in addiction has created a 
new range of treatment options that directly 
target dysregulated brain circuits in order 
to normalize functionality, e.g., deep brain 
stimulation (Luigjes et al., 2012). However, 
what remained unknown so far were the 
consequences of psychoactive drug abuse 
taking place on a cellular level and eventu-
ally leading toward dysfunctional circuitry.
In their recently published manuscript 
Pascoli et al. (2011) elucidate the molecular 
mechanisms following cocaine exposure. By 
using an animal model the authors dem-
onstrate that cocaine potentiates the dopa-
minergic transmission in D1 expressing 
accumbal neurons. These early changes 
in synaptic plasticity may initiate cocaine 
dependency and thereby precede the patho-
logical changes that characterize addictive 
behavior. Most interestingly, these cocaine 
evoked neuroplastic changes are reversed 
under an inhibitory optogenetic stimula-
tion procedure. The impact of these find-
ings for new experimental therapies, such 
as transcranial magnetic stimulation and 
DBS, is touched on by the authors but is – 
according to our judgment – even of greater 
relevance than it is expressed in the article.
Since the first description of a patient, 
whose alcohol addictive behavior was posi-
tively influenced by high-frequency accum-
bal DBS (Kuhn et al., 2007), additional case 
reports hint to a beneficial therapeutic effect 
of the method in addiction (for an over-
view, see Luigjes et al., 2012). By mimicking 
different aspects of addiction, translational 
animal research indicates that stimulation 
of the nucleus accumbens has a significant 
positive impact on related behavioral pat-
terns (Liu et al., 2008; Vassoler et al., 2008; 
Knapp et al., 2009; Henderson et al., 2010). 
The generalizability of these beneficial 
effects of DBS on different drug-addictions 
has yet to be established but seems promis-
ing given the broad range of psychotrophic 
substances, including cocaine, alcohol, or 
opioids, tested in animal models.
Although the mechanisms of deep brain 
stimulation are, despite its decade-long 
application, not yet fully understood it has 
been argued that the modulation of dopa-
minergic transmission – especially in the 
context of addictive disorders – underlies 
the therapeutic effect. While this assump-
tion could only be demonstrated for the 
rat nucleus accumbens (Sesia et al., 2010), 
PET-imaging studies in humans show alter-
ations of dopamine release and dopamine 
binding potential under thalamic stimu-
lation (Kuhn et al., 2012). The regulative 
function of the ventral striatum, includ-
ing the nucleus accumbens, however, is 
not only relevant to addiction but also to 
other psychiatric disorders. Its unimpaired 
functioning, however, does not only depend 
on a subtle interaction between D1 and D2 
receptor activations (Goto and Grace, 2008) 
but also on a D1-associated co-activation 
of NMDA-receptors, thereby also involving 
the glutamatergic system (Lee et al., 2011). 
Furthermore, the differential involvement of 
receptor types and the interaction of tonic 
levels and phasic burst and the timing of 
synaptic availability of dopamine add to 
the complexity of these regulatory processes.
The influence of impaired dopamin-
ergic functioning on cognition and neu-
ronal plasticity has been much debated. It 
is assumed that an activation of accumbal 
D1 receptors by phasic dopamine release 
facilitates limbic afferents and promotes 
cortical synaptic plasticity. At the same 
time, D2 receptor activation might promote 
the reinforcement of prefrontal influences, 
which is especially relevant in the context 
of addiction given the reduced density of 
both striatal and accumbal D2 receptors in 
addicted patients (Lee et al., 2011; Volkow 
et al., 2011).
The results of Pascoli et al. (2011) help 
explain the concept of an impaired nucleus 
accumbens function in addiction (Adinoff, 
2004) by pointing to the selective impact 
of psychotrophic substances on the neu-
roplasticity of D1 receptor neurons and a 
possible restoration through focal long-
term depression.
The short-term application of psycho-
tropic substances, in this case cocaine, 
apparently triggers a fast modification of 
D1-receptor expression in terms of focal 
synaptic plasticity and could, hence, bring 
forth a lasting shift in the D1/D2 ratio, 
which eventually might lead to a fortifica-
tion of limbic and drug-associated afferents.
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Current pharmacologic approaches 
to ameliorate the dysregulated dopamin-
ergic system are not sufficiently effective 
(Spanagel and Vengeline, 2012). Yet, selec-
tive inhibitory optogenetic stimulation is 
able to reverse early drug associated altera-
tions and thus potentially interrupts the 
cascade leading to or upholding addiction 
(Pascoli et al., 2011). In our opinion, this 
new model of NAcc interaction and manip-
ulation through stimulation supports the 
application of DBS as a promising approach 
in the treatment of otherwise refractory 
severe substance addiction.
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